TRIUS THERAPEUTICS INC (TSRX) financial statements (2021 and earlier)

Company profile

Business Address 6310 NANCY RIDGE DR SUITE 105
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments66
Cash and cash equivalents16
Short-term investments50
Receivables6
Prepaid expense and other current assets2
Total current assets:74
Noncurrent Assets
Property, plant and equipment1
Restricted cash and investments0
Prepaid expense and other noncurrent assets0
Other undisclosed noncurrent assets0
Total noncurrent assets:1
TOTAL ASSETS:75
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18
Accounts payable7
Accrued liabilities8
Employee-related liabilities3
Deferred revenue and credits0
Other undisclosed current liabilities1
Total current liabilities:18
Noncurrent Liabilities
Total liabilities:18
Stockholders' equity
Stockholders' equity attributable to parent57
Common stock0
Additional paid in capital206
Accumulated other comprehensive income0
Accumulated deficit(149)
Total stockholders' equity:57
TOTAL LIABILITIES AND EQUITY:75

Income statement (P&L) ($ in millions)

12/31/2012
Revenue, net13
Gross profit:27
Operating expenses(84)
Operating loss:(57)
Nonoperating income3
Net loss available to common stockholders, diluted:(54)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(54)
Comprehensive loss:(54)
Other undisclosed comprehensive income, net of tax, attributable to parent0
Comprehensive loss, net of tax, attributable to parent:(54)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: